DexCom Inc (DXCM)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	541,500	377,000	357,500	292,500	341,200	244,100	230,200	257,700	216,900	633,500	618,400	586,300	549,700	231,100	204,700	147,900	101,100	-171,300	-170,500	-129,800
Revenue (ttm)	US$ in thousands	3,603,200	3,380,700	3,175,600	3,001,700	2,889,200	2,740,300	2,599,600	2,478,000	2,333,800	2,206,500	2,058,200	1,914,400	1,823,900	1,754,600	1,659,800	1,555,100	1,426,800	1,302,000	1,187,500	1,108,600
Net profit margin		15.03%	11.15%	11.26%	9.74%	11.81%	8.91%	8.86%	10.40%	9.29%	28.71%	30.05%	30.63%	30.14%	13.17%	12.33%	9.51%	7.09%	-13.16%	-14.36%	-11.71%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $541,500K ÷ $3,603,200K
= 15.03%

Over the past eight quarters, Dexcom Inc's net profit margin has shown some variability. The company's net profit margin ranged from 7.47% to 14.95% during this period.

In the most recent quarter, Q4 2023, the net profit margin increased to 14.95%, indicating that Dexcom Inc was able to generate a higher percentage of profit from its revenue compared to previous quarters. This improvement suggests effective cost management or increased revenue relative to expenses.

However, it is worth noting that the net profit margin fluctuated in the range of 8.24% to 11.73% in the quarters preceding Q4 2023. This variability may indicate fluctuations in expenses, revenue, or a combination of both during these periods.

Overall, Dexcom Inc's net profit margin trend demonstrates some level of volatility, with fluctuations quarter to quarter. Further analysis into the factors influencing these changes would provide a more comprehensive understanding of the company's financial performance.